07500 CSOP Hang Seng Index Daily (-2x) Inverse Product
- 4.710
- +0.006+0.13%
截至二零二三年十二月三十一日止的經審核賬目
Announcement Highlights | NIO's Q4 revenue increased 6.5% year on year to 17.103 billion yuan; Great Wall Motor's February sales increased 4.12% year on year
China Electric Power's combined total electricity sales volume in January was 10.3482 million megawatt-hours, an increase of 41.15% over the previous year; Shanghai Pharmaceutical: Norepinephrine bitartrate injection passed the generic drug consistency evaluation.
Announcement Highlights: NetEase Q4 net revenue increased 7% year-on-year to 27.14 billion yuan; Yuexiu Real Estate acquired land for 1,414 billion yuan
NetEase Cloud Music's revenue in 2023 was 7.87 billion yuan, turning a loss into a profit for the first time, and gross margin rose to 26.7%; Pacific Shipping had a turnover of US$2,297 billion in 2023, a year-on-year decrease of 30.02%.
Selected Announcements | Country Garden was petitioned for liquidation by Ever Credit; China Exempts China to invest an additional 1.1 billion yuan in duty-free shopping
Nine Dragons Paper announced interim results, with shareholders accounting for a profit of 292 million yuan, turning a year-on-year loss into a profit; Fuzhikang Group issued a profit warning and expects a consolidated net loss of about US$120.8 million in 2023.
Selected Announcements | Haohai Biotech's annual net profit to mother increased by 130% year-on-year; Zijin Mining's 17.5 billion yuan mine expansion project approved
Huahong Semiconductor: Net profit due to mother decreased by 35.64% year on year in 2023; Times Electric: net profit to mother increased by 21.51% year on year in 2023; BYD Chairman and CEO Wang Chuanfu proposed to repurchase A-shares to 400 million yuan.
Selected Announcements | New Oriental and Yu Minhong promised to purchase a total of HK$700 million Dongfang Selected Shares; Yao Ming Joint Inc. expects adjusted net profit to increase by more than 100% last year
Saisheng Pharmaceutical: The Phase III clinical trial of Vaborem® in China completed the enrollment of all subjects; Xianruida Healthcare: The registration application for PERIDGE® was approved by the China National Drug Administration.
Economists Warned of Looming Signs of Reflation, And Red Sea Attack Is Not the Only Reason
The continued impact of the recent Red Sea incident has aroused alarm about reflation. One reason for lower inflation in 2023 is the high base effect from the previous year, which may not be the case in 2024. The easing of the financial conditions index and record-high housing prices are the latest signs of inflation accelerating.
Announcement selection: Great Wall Motor's sales last month increased by more than 40% year on year; China Railway Construction recently won a bid of 73.298 billion yuan for a major project
C&D International Group: The cumulative contract sales amount in 2023 was about 137.96 billion yuan, an increase of 13.5% over the previous year; Kingsley Biotech: Legend Biotech and Novartis completed a global licensing agreement.
Selected Announcements｜Alibaba Pictures completed the share acquisition of Damai.com; MODERN DENTAL's revenue for the first three quarters increased by about 13% year-on-year to HK$2,363 billion
PhysicsHealth plans to acquire 42.88% of Xinya's shares for HK$115 million to promote the expansion of the medical laboratory testing market; on November 30, Tencent Holdings spent HK$400 million to repurchase 1.24 million shares.
Breakdown of US Monthly Retail Sales Data, in One Chart
Retail sales in the United States decreased by 0.1% month-over-month in October 2023, putting an end to a six-month streak of increases and compared with the market consensus of a 0.3% decline.
Here's the Inflation Breakdown for October, in One Chart
Food costs were up 3.3% compared with one year ago, down from 3.7% YoY compared to last month.
October CPI Preview: Inflation Moves Closer to Fed's Target
Bloomberg data shows YoY CPI inflation will fall to 3.3% (vs. 3.7% prior), with annual core inflation remaining at 4.1%.
PCE Price Index Preview: Fed Still Stuck in the Last Mile of Lowering Inflation
The Bureau of Economic Analysis will release the Personal Consumption Expenditure and the price index at 8:30 ET on Friday. The previously announced CPI price for August showed core inflation continued declining but headline inflation ticked up again.
Consumer Spending May Continue Growing Until 2024, But Income Disparity Is Alarming
Benefiting from the phased decline in inflation, according to Goldman Sachs' estimate, residents' real income is expected to increase by 4% in Q4 2023. This growing trend may continue until 2024.
Here's the Inflation Breakdown for August, in One Chart
Food costs were up 4.3% compared with one year ago, down from 4.9% compared to last month.
Today's Pre-Market Stock Movers and Top Ratings: ADBE, RH, GS, GILD and More
Adobe stock rose 1.6% after Mizuho Securities upgraded the computer software company to ‘buy’ from ‘neutral’, saying it is well-positioned to capitalize on digital transformation with its highly comprehensive end-to-end offering.
Today's Pre-Market Stock Movers And Top Ratings: UBS, DG, VSCO, PLTR and More
Salesforce jumped 6.2% following its earnings beat after the bell Wednesday. Adjusted earnings per share came in at $2.12 for the second quarter, versus the consensus estimate of $1.90, per Refinitiv. Revenue was $8.60 billion, topping the $8.53 expected.
CSOP Hang Seng Index Daily (-2x) Inverse Product: UNAUDITED SEMI-ANNUAL ACCOUNTS AS AT 30 JUNE 2023
August Nonfarm Payroll Preview: Incoming Data is Expected to Confirm the Labor Market's Cooling Down
JOLTS data released on Tuesday and ADP private payrolls on Wednesday already surprised the market with lower than expected employment data, stimulating market gains this week. The market expects the median non-farm payrolls in August to be 170k.
Conflicting Data Leaves Europe in a Dilemma Over Whether to Raise Rates, And What It Means for The US
When European economic momentum slowed down significantly, ECB struggles in debate over whether to raise rates.